This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Emtriva (Emtricitabine) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (19)
Death (2)
Reports by Reaction Type
Stillbirth (8),
PRE-Eclampsia (8),
Maternal Exposure During Pregnancy (5),
Immune Reconstitution Syndrome (4),
Renal Tubular Disorder (3),
Condition Aggravated (3),
Anaemia (2),
Abdominal Pain (1),
Agitation (1),
Confusional State (1),
Drug Interaction (1),
Suicidal Ideation (1)
Possible Emtriva side effects in 44 year old female
Reported by a individual with unspecified qualification from Spain on 2012-08-08
Patient: 44 year old female
Reactions: Immune Reconstitution Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Viread
Indication: HIV Infection
Efavirenz
Indication: HIV Infection
Emtriva
Indication: HIV Infection
Other drugs received by patient: Methylprednisolone; Prednisone TAB
Possible Emtriva side effects in 54 year old male
Reported by a physician from Japan on 2012-08-06
Patient: 54 year old male
Reactions: Immune Reconstitution Syndrome, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Emtriva
Indication: HIV Infection
Efavirenz
Indication: HIV Infection
Viread
Indication: HIV Infection
Possible Emtriva side effects in 37 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10
Patient: 37 year old male
Reactions: Renal Failure Acute
Drug(s) suspected as cause:
Emtriva
Indication: HIV Infection
Viread
Indication: HIV Infection
Other drugs received by patient: Diflucan; Pantoprazole; Raltegravir; Ceftriaxon; Trimethoprim; Enoxaparin; Mirtazapine; Sulfamethoxazol; Folic Acid
Possible Emtriva side effects in 54 year old male
Reported by a physician from Japan on 2012-06-15
Patient: 54 year old male
Reactions: Immune Reconstitution Syndrome, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Viread
Indication: HIV Infection
Emtriva
Indication: HIV Infection
Efavirenz
Indication: HIV Infection
Possible Emtriva side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16
Patient: 25 year old female
Reactions: Stillbirth, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Emtriva
Dosage: 200mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Combivir
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-05
End date: 2011-07-05
Reyataz
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Possible Emtriva side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16
Patient: 25 year old female
Reactions: Stillbirth, PRE-Eclampsia
Drug(s) suspected as cause:
Combivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Truvada
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Emtriva
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Possible Emtriva side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-04
Patient: 25 year old female
Reactions: Stillbirth, PRE-Eclampsia
Drug(s) suspected as cause:
Truvada
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Combivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Emtriva
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Possible Emtriva side effects in 25 year old female
Reported by a physician from United States on 2012-02-09
Patient: 25 year old female
Reactions: Stillbirth, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Emtriva
Dosage: 200mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Combivir
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-05
End date: 2011-07-05
Reyataz
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Possible Emtriva side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-08
Patient: 25 year old female
Reactions: Stillbirth, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Combivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Truvada
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Emtriva
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Possible Emtriva side effects in 25 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-07
Patient: 25 year old female
Reactions: Stillbirth, Maternal Exposure During Pregnancy, PRE-Eclampsia
Drug(s) suspected as cause:
Emtriva
Dosage: 200mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Truvada
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Combivir
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-05
End date: 2011-07-05
Reyataz
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Possible Emtriva side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-06
Patient: female
Reactions: Maternal Exposure During Pregnancy, Stillbirth, PRE-Eclampsia
Drug(s) suspected as cause:
Emtriva
Dosage: 200mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Combivir
Dosage: 1tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-05
End date: 2011-07-05
Truvada
Dosage: 300mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Reyataz
Dosage: 400mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Possible Emtriva side effects in 51 year old male
Reported by a consumer/non-health professional from France on 2012-02-01
Patient: 51 year old male
Reactions: Renal Tubular Disorder, Condition Aggravated
Drug(s) suspected as cause:
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
End date: 2011-05-03
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-21
End date: 2011-05-03
Other drugs received by patient: Zoledronoc Acid; Crestor
Possible Emtriva side effects in male
Reported by a physician from France on 2012-02-01
Patient: male
Reactions: Hypophosphataemia, Renal Tubular Disorder, Condition Aggravated, Hypercalcaemia
Drug(s) suspected as cause:
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-21
End date: 2011-05-03
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2010-07-06
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2010-07-06
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-21
End date: 2011-05-03
Other drugs received by patient: Raltegravir; Crestor; Alcasta
Possible Emtriva side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-31
Patient: female
Reactions: Stillbirth, PRE-Eclampsia
Drug(s) suspected as cause:
Emtriva
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Truvada
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Norvir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-07-05
Combivir
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Kaletra
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-05-09
End date: 2011-07-05
Possible Emtriva side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-27
Patient: male
Reactions: Renal Tubular Disorder, Condition Aggravated
Drug(s) suspected as cause:
Viread
Dosage: 0.5 df, unk
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
Reyataz
Dosage: 1 df, qd
Administration route: Oral
Start date: 2009-12-21
End date: 2011-05-03
Norvir
Dosage: 1 df, unk
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
End date: 2011-05-03
Emtriva
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2009-03-26
Reyataz
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2009-12-21
End date: 2011-05-03
Other drugs received by patient: Crestor; Zoledronoc Acid
Possible Emtriva side effects in male
Reported by a physician from Japan on 2011-11-28
Patient: male
Reactions: Immune Reconstitution Syndrome, Hepatitis B
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Viread
Administration route: Oral
Indication: HIV Antibody Positive
Start date: 2009-10-01
Emtriva
Administration route: Oral
Indication: HIV Antibody Positive
Start date: 2009-10-01
Norvir
Administration route: Oral
Indication: HIV Antibody Positive
Start date: 2009-10-01
Prezista
Administration route: Oral
Indication: HIV Antibody Positive
Start date: 2009-10-01
Possible Emtriva side effects in male
Reported by a consumer/non-health professional from France on 2011-11-09
Patient: male
Reactions: Abdominal Pain, Nausea, Diarrhoea, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Truvada
Dosage: 1 df, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-01-01
End date: 2011-07-01
Emtriva
Dosage: 200 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2011-07-01
End date: 2011-09-01
Other drugs received by patient: Omacor / 06312301 /; Aspirin; Atenolol; Humalog; Flagyl; Kaletra; Rovamycine / 00074401 /; Crestor
Possible Emtriva side effects in
Reported by a physician from United Kingdom on 2011-10-26
Patient:
Reactions: Confusional State, Agitation, Malaise
Adverse event resulted in: death
Drug(s) suspected as cause:
Viread
Indication: Asymptomatic HIV Infection
Efavirenz
Administration route: Oral
Indication: Asymptomatic HIV Infection
Start date: 2011-08-03
End date: 2011-08-13
Emtriva
Indication: Asymptomatic HIV Infection
Other drugs received by patient: Nevirapine; Combivir
Possible Emtriva side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-10-24
Patient: 44 year old male
Reactions: Anxiety, Paranoia, Psychomotor Skills Impaired, Drug Interaction, Depression, Psychiatric Decompensation, Tearfulness, Suicidal Ideation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Isentress
Administration route: Oral
Tenofovir
Clonazepam
Risperidone
Bupropion Hydrochloride
Citalopram
Quetiapine Fumarate
Reyataz
Emtriva
Ritonavir
|